Home / TGF-beta 1 / Human TGF-beta 1 Protein

Human TGF-beta 1 Protein

Catalog #: 100-B
43 Citations 4 Reviews Datasheet / COA / SDS
Newer Version Available: 7754-BH
NEW

Discontinued Product

100-B has been discontinued and is replaced by 7754-BH. 240-B.

Human TGF-beta 1 Protein Bioactivity
2 Images
Product Details
Citations (43)
FAQs
Reviews (4)
Summary Product Datasheets Carrier Free Data Images Reconstitution Calculator Background Related Research Areas

Human TGF-beta 1 Protein Summary

Product Specifications

Purity
>97%, by SDS-PAGE under reducing conditions and visualized by silver stain.
Endotoxin Level
<0.10 EU per 1 μg of the protein by the LAL method.
Activity
Measured by its ability to inhibit the IL-4-dependent proliferation of HT‑2 mouse T cells. Tsang, M. et al. (1995) Cytokine 7:389. The ED50 for this effect is 0.04-0.2 ng/mL.
Source
Human platelet-derived TGF-beta 1 protein
The human platelets used for the isolation of this product were certified by the supplier to be HIV-1 and HBsAg negative at the time of shipment. Human blood products should always be treated in accordance with universal handling precautions.
Structure / Form
Disulfide-linked homodimer
SDS-PAGE
12 kDa, reducing conditions

Product Datasheets

You must select a language.

x

100-B (with carrier)

Product Datasheet
COA
SDS

You must select a language.

x

100-B/CF (carrier free)

Discontinued Product

100-B

Formulation Lyophilized from a 0.2 μm filtered solution in Acetonitrile and TFA with BSA as a carrier protein.
Reconstitution Reconstitute at 10 μg/mL in sterile 4 mM HCl containing at least 0.1% human or bovine serum albumin.
Shipping The product is shipped at ambient temperature. Upon receipt, store it immediately at the temperature recommended below.
Stability & Storage: Use a manual defrost freezer and avoid repeated freeze-thaw cycles.
  • 12 months from date of receipt, -20 to -70 °C as supplied.
  • 1 month, 2 to 8 °C under sterile conditions after reconstitution.
  • 3 months, -20 to -70 °C under sterile conditions after reconstitution.

Scientific Data

Bioactivity Human TGF-beta 1 Protein Bioactivity View Larger

Human TGF-beta 1 (Catalog # 100-B) inhibits Recombinant Mouse IL-4 (Catalog # 404-ML) induced cell proliferation in the HT-2 mouse T cell line. The ED50 for this effect is 0.04-0.2 ng/mL.

SDS-PAGE Human TGF-beta 1 Protein SDS-PAGE View Larger

1 μg/lane of Recombinant Human TGF-beta 1 was resolved with SDS-PAGE under reducing (R) and non-reducing (NR) conditions and visualized by silver staining, showing single bands at 12 kDa and 24 kDa, respectively.

Reconstitution Calculator

Reconstitution Calculator

The reconstitution calculator allows you to quickly calculate the volume of a reagent to reconstitute your vial. Simply enter the mass of reagent and the target concentration and the calculator will determine the rest.

=
÷

Background: TGF-beta 1

TGF-beta 1 (transforming growth factor beta 1) is one of three closely related mammalian members of the large TGF-beta  superfamily that share a characteristic cysteine knot structure (1-7). TGF-beta 1, -2 and -3 are highly pleiotropic cytokines that are proposed to act as cellular switches that regulate processes such as immune function, proliferation and epithelial-mesenchymal transition (1-4). Each TGF-beta isoform has some non-redundant functions; for TGF-beta 1, mice with targeted deletion show defects in hematopoiesis and endothelial differentiation, and die of overwhelming inflammation (2). Human TGF-beta 1 cDNA encodes a 390 amino acid (aa) precursor that contains a 29 aa signal peptide and a 361 aa proprotein (8). A furin-like convertase processes the proprotein to generate an N-terminal 249 aa latency-associated peptide (LAP) and a C-terminal 112 aa mature TGF-  beta 1 (8, 9). Disulfide-linked homodimers of LAP and TGF-beta 1 remain non-covalently associated after secretion, forming the small latent TGF-beta 1 complex (8-10). Covalent linkage of LAP to one of three latent TGF-beta binding proteins (LTBPs) creates a large latent complex that may interact with the extracellular matrix (9, 10). TGF-beta is activated from latency by pathways that include actions of the protease plasmin, matrix metalloproteases, thrombospondin 1 and a subset of integrins (10). Mature human TGF-beta 1 shares 100% aa identity with pig, dog and cow TGF-beta 1, and 99% aa identity with mouse, rat and horse TGF-beta 1. It demonstrates cross-species activity (1). TGF-beta 1 signaling begins with high-affinity binding to a type II ser/thr kinase receptor termed TGF-beta  RII. This receptor then phosphorylates and activates a second ser/thr kinase receptor, TGF-beta  RI (also called activin receptor-like kinase (ALK) -5), or alternatively,
ALK‑1.This complex phosphorylates and activates Smad proteins that regulate transcription (3, 11, 12). Contributions of the accessory receptors betaglycan (also known as TGF-beta  RIII) and endoglin, or use of Smad-independent signaling pathways, allow for disparate actions observed in response to TGF-beta in different contexts (11).

References
  1. Derynck, R. and K. Miyazono (2008) “TGF-beta and the TGF-beta Family” in The TGF-beta Family, Derynck, R. and K. Miyazono eds., Cold Spring Harbor Laboratory Press, p. 29.
  2. Dunker, N. & K. Krieglstein, 2000, Eur. J. Biochem. 267:6982.
  3. Wahl, S.M. (2006) Immunol. Rev. 213:213.
  4. Chang, H. et al. (2002) Endocr. Rev. 23:787.
  5. Lin, J.S. et al. (2006) Reproduction 132:179.
  6. Hinck, A.P. et al. (1996) Biochemistry 35:8517.
  7. Mittl, P.R.E. et al. (1996) Protein Sci. 5:1261.
  8. Derynck, R. et al. (1985) Nature 316:701.
  9. Miyazono, K. et al. (1988) J. Biol. Chem. 263:6407.
  10. Oklu, R. and R. Hesketh (2000) Biochem. J. 352:601.
  11. de Caestecker, M. et al. (2004) Cytokine Growth Factor Rev. 15:1.
  12. Zuniga, J.E. et al. (2005) J. Mol. Biol. 354:1052.
Long Name
Transforming Growth Factor beta 1
Entrez Gene IDs
7040 (Human); 21803 (Mouse); 59086 (Rat); 397078 (Porcine); 100033900 (Equine)
Alternate Names
CEDLAP; DPD1; latency-associated peptide; TGF beta; TGF beta1; TGFB; TGFB1; TGF-beta 1 protein; TGFbeta 1; TGF-beta 1; TGFbeta; TGF-beta-1; transforming growth factor beta-1; transforming growth factor, beta 1

Citations for Human TGF-beta 1 Protein

R&D Systems personnel manually curate a database that contains references using R&D Systems products. The data collected includes not only links to publications in PubMed, but also provides information about sample types, species, and experimental conditions.

43 Citations: Showing 1 - 10
Filter your results:

Filter by:

  1. Inhibiting stromal Class I HDACs curbs pancreatic cancer progression
    Authors: Liang, G;Oh, TG;Hah, N;Tiriac, H;Shi, Y;Truitt, ML;Antal, CE;Atkins, AR;Li, Y;Fraser, C;Ng, S;Pinto, AFM;Nelson, DC;Estepa, G;Bashi, S;Banayo, E;Dai, Y;Liddle, C;Yu, RT;Hunter, T;Engle, DD;Han, H;Von Hoff, DD;Downes, M;Evans, RM;
    Nature communications
    Species: Human
    Sample Types: Whole Cells
    Applications: Bioassay
  2. Inhibiting Stromal Class I HDACs Curbs Pancreatic Cancer Progression
    Authors: Liang, G;Oh, TG;Hah, N;Tiriac, H;Shi, Y;Truitt, ML;Antal, CE;Atkins, AR;Li, Y;Fraser, C;Ng, S;Pinto, AFM;Nelson, DC;Estepa, G;Bashi, S;Banayo, E;Dai, Y;Liddle, C;Yu, RT;Hunter, T;Engle, DD;Han, H;Von Hoff, DD;Downes, M;Evans, RM;
    bioRxiv : the preprint server for biology
    Species: Human
    Sample Types: Whole Cells
    Applications: Bioassay
  3. UDP-glucose dehydrogenase (UGDH) activity is suppressed by peroxide and promoted by PDGF in fibroblast-like synoviocytes: Evidence of a redox control mechanism
    Authors: R Chandrasek, C Mathieu, R Sheth, AP Cheng, D Fong, R McCormack, H El-Gabalaw, S Alishetty, M Paige, CD Hoemann
    PLoS ONE, 2022-09-15;17(9):e0274420.
    Species: Human
    Sample Types: Whole Cells
    Applications: Bioassay
  4. A disease-driver population within interstitial cells of human calcific aortic valves identified via single-cell and proteomic profiling
    Authors: JL Decano, Y Iwamoto, S Goto, JY Lee, JT Matamalas, A Halu, M Blaser, LH Lee, B Pieper, S Chelvanamb, J Silva-Nico, F Bartoli-Le, H Higashi, H Shibata, P Vyas, J Wang, E Gostjeva, SC Body, SA Singh, M Aikawa, E Aikawa
    Cell Reports, 2022-04-12;39(2):110685.
    Species: Human
    Sample Types: Whole Cells
    Applications: Bioassay
  5. LPA1 antagonist BMS-986020 changes collagen dynamics and exerts antifibrotic effects in vitro and in patients with idiopathic pulmonary fibrosis
    Authors: BE Decato, DJ Leeming, JMB Sand, A Fischer, S Du, SM Palmer, M Karsdal, Y Luo, A Minnich
    Respiratory Research, 2022-03-18;23(1):61.
    Species: Human
    Sample Types: Whole Cells
    Applications: Bioassay
  6. E4 engages uPAR and enolase-1 and activates urokinase to exert antifibrotic effects
    Authors: S Sharma, T Watanabe, T Nishimoto, T Takihara, L Mlakar, XX Nguyen, M Sanderson, Y Su, RA Chambers, C Feghali-Bo
    JCI Insight, 2021-12-22;6(24):.
    Species: Human
    Sample Types: Whole Cells
    Applications: Bioassay
  7. PP2A Catalytic Subunit alpha promotes fibroblast activation and kidney fibrosis via ERK pathway
    Authors: Q Lu, M Tan, Q Hou, M Wang, C Dai
    Cellular Signalling, 2021-11-13;90(0):110187.
    Species: Mouse
    Sample Types: Whole Cells
    Applications: Bioassay
  8. Red-COLA1: a human fibroblast reporter cell line for type I collagen transcription
    Authors: HH Wong, SH Seet, CC Bascom, RJ Isfort, F Bard
    Sci Rep, 2020-11-12;10(1):19723.
    Species: Human
    Sample Types: Whole Cells
    Applications: Cell Culture
  9. Prolonged Scar-in-a-Jar: an in vitro screening tool for anti-fibrotic therapies using biomarkers of extracellular matrix synthesis
    Authors: SR Rønnow, RQ Dabbagh, F Genovese, CB Nanthakuma, VJ Barrett, RB Good, S Brockbank, S Cruwys, H Jessen, GL Sorensen, MA Karsdal, DJ Leeming, JMB Sand
    Respir. Res., 2020-05-07;21(1):108.
    Species: Human
    Sample Types: Whole Cells
    Applications: Bioassay
  10. Involvement of GPx4-Regulated Lipid Peroxidation in Idiopathic Pulmonary Fibrosis Pathogenesis
    Authors: K Tsubouchi, J Araya, M Yoshida, T Sakamoto, T Koumura, S Minagawa, H Hara, Y Hosaka, A Ichikawa, N Saito, T Kadota, Y Kurita, K Kobayashi, S Ito, Y Fujita, H Utsumi, M Hashimoto, H Wakui, T Numata, Y Kaneko, S Mori, H Asano, H Matsudaira, T Ohtsuka, K Nakayama, Y Nakanishi, H Imai, K Kuwano
    J. Immunol., 2019-09-18;0(0):.
    Species: Human
    Sample Types: Whole Cells
    Applications: Bioassay
  11. IL-23R Signaling Plays No Role in Myocardial Infarction
    Authors: E Engelowski, NF Modares, S Gorressen, P Bouvain, D Semmler, C Alter, Z Ding, U Flögel, J Schrader, H Xu, PA Lang, J Fischer, DM Floss, J Scheller
    Sci Rep, 2018-11-20;8(1):17078.
    Species: Mouse
    Sample Types: Whole Cells
    Applications: Bioassay
  12. Activation of Ras in the Vascular Endothelium Induces Brain Vascular Malformations and Hemorrhagic Stroke
    Authors: QF Li, B Decker-Roc, A Bajaj, K Pumiglia
    Cell Rep, 2018-09-11;24(11):2869-2882.
    Species: Human
    Sample Types: Cell Culture Treatment
    Applications: Bioassay
  13. Protein kinase C alpha drives fibroblast activation and kidney fibrosis by stimulating autophagic flux
    Authors: X Xue, J Ren, X Sun, Y Gui, Y Feng, B Shu, W Wei, Q Lu, Y Liang, W He, J Yang, C Dai
    J. Biol. Chem., 2018-05-23;0(0):.
    Species: Rat
    Sample Types: Whole Cells
    Applications: Bioassay
  14. Aloperine Protects Mice against DSS-Induced Colitis by PP2A-Mediated PI3K/Akt/mTOR Signaling Suppression
    Authors: X Fu, F Sun, F Wang, J Zhang, B Zheng, J Zhong, T Yue, X Zheng, JF Xu, CY Wang
    Mediators Inflamm., 2017-09-19;2017(0):5706152.
    Species: Mouse
    Sample Types: Whole Cells
    Applications: Bioassay
  15. Omega-3 Polyunsaturated Fatty Acids Attenuate Fibroblast Activation and Kidney Fibrosis Involving MTORC2 Signaling Suppression
    Authors: Z Zeng, H Yang, Y Wang, J Ren, Y Dai, C Dai
    Sci Rep, 2017-04-10;7(0):46146.
    Species: Rat
    Sample Types: Whole Cells
    Applications: Bioassay
  16. Quercetin Inhibits Fibroblast Activation and Kidney Fibrosis Involving the Suppression of Mammalian Target of Rapamycin and ?-catenin Signaling
    Authors: J Ren, J Li, X Liu, Y Feng, Y Gui, J Yang, W He, C Dai
    Sci Rep, 2016-04-07;6(0):23968.
    Species: Rat
    Sample Types: Whole Cells
    Applications: Bioassay
  17. Rictor/mTORC2 signaling mediates TGFbeta1-induced fibroblast activation and kidney fibrosis.
    Authors: Li J, Ren J, Liu X, Jiang L, He W, Yuan W, Yang J, Dai C
    Kidney Int, 2015-05-13;88(3):515-27.
    Species: Rat
    Sample Types: Whole Cells
    Applications: Bioassay
  18. Recruitment of Matrix Metalloproteinase-9 (MMP-9) to the Fibroblast Cell Surface by Lysyl Hydroxylase 3 (LH3) Triggers Transforming Growth Factor-beta (TGF-beta) Activation and Fibroblast Differentiation.
    Authors: Dayer C, Stamenkovic I
    J Biol Chem, 2015-03-30;290(22):13763-78.
    Species: Human
    Sample Types: Whole Cells
    Applications: Bioassay
  19. Autocrine CSF1R signaling mediates switching between invasion and proliferation downstream of TGFbeta in claudin-low breast tumor cells.
    Authors: Patsialou A, Wang Y, Pignatelli J, Chen X, Entenberg D, Oktay M, Condeelis J
    Oncogene, 2014-08-04;34(21):2721-31.
    Species: Human
    Sample Types: Whole Cells
    Applications: Bioassay
  20. Opposing roles for Smad2 and Smad3 in peritoneal fibrosis in vivo and in vitro.
    Authors: Duan W, Yu X, Huang X, Yu J, Lan H
    Am J Pathol, 2014-06-10;184(8):2275-84.
    Species: Human
    Sample Types: Whole Cells
    Applications: Bioassay
  21. Autophagy fosters myofibroblast differentiation through MTORC2 activation and downstream upregulation of CTGF.
    Authors: Bernard M, Dieude M, Yang B, Hamelin K, Underwood K, Hebert M
    Autophagy, 2014-01-01;10(12):2193-207.
    Species: Human
    Sample Types: Whole Cells
    Applications: Bioassay
  22. Induction of high temperature requirement A1, a serine protease, by TGF-beta1 in articular chondrocytes of mouse models of OA.
    Authors: Xu L, Golshirazian I, Asbury B, Li Y
    2013-10-18;0(0):.
    Species: Human
    Sample Types: Whole Cells
    Applications: Bioassay
  23. Rheb/mTORC1 signaling promotes kidney fibroblast activation and fibrosis.
    Authors: Jiang L, Xu L, Mao J, Li J, Fang L, Zhou Y, Liu W, He W, Zhao A, Yang J, Dai C
    J Am Soc Nephrol, 2013-05-09;24(7):1114-26.
    Species: Rat
    Sample Types: Whole Cells
    Applications: Bioassay
  24. Chemotherapy-triggered cathepsin B release in myeloid-derived suppressor cells activates the Nlrp3 inflammasome and promotes tumor growth.
    Authors: Bruchard M, Mignot G, Derangere V, Chalmin F, Chevriaux A, Vegran F, Boireau W, Simon B, Ryffel B, Connat J, Kanellopoulos J, Martin F, Rebe C, Apetoh L, Ghiringhelli F
    Nat Med, 2012-12-02;19(1):57-64.
    Species: Mouse
    Sample Types: Whole Cells
    Applications: Bioassay
  25. Transforming growth factor beta induces sensory neuronal hyperexcitability, and contributes to pancreatic pain and hyperalgesia in rats with chronic pancreatitis.
    Authors: Zhu Y, Colak T, Shenoy M, Liu L, Mehta K, Pai R, Zou B, Xie X, Pasricha P
    Mol Pain, 2012-09-11;8(0):65.
    Species: Rat
    Sample Types: In Vivo
    Applications: Bioassay
  26. TGF-beta signaling to T cells inhibits autoimmunity during lymphopenia-driven proliferation.
    Authors: Zhang N, Bevan MJ
    Nat. Immunol., 2012-05-27;13(7):667-73.
    Species: Mouse
    Sample Types: Whole Cells
    Applications: Bioassay
  27. Severe dermatitis with loss of epidermal Langerhans cells in human and mouse zinc deficiency.
    Authors: Kawamura T, Ogawa Y, Nakamura Y
    J. Clin. Invest., 2012-01-03;122(2):722-32.
    Species: Human
    Sample Types: Whole Cells
    Applications: Bioassay
  28. A role for IL-27p28 as an antagonist of gp130-mediated signaling.
    Authors: Stumhofer JS, Tait ED, Quinn WJ, Hosken N, Spudy B, Goenka R, Fielding CA, O'Hara AC, Chen Y, Jones ML, Saris CJ, Rose-John S, Cua DJ, Jones SA, Elloso MM, Grotzinger J, Cancro MP, Levin SD, Hunter CA
    Nat. Immunol., 2010-11-07;11(12):1119-26.
    Species: Mouse
    Sample Types: Whole Cells
    Applications: Bioassay
  29. B and T lymphocyte attenuator suppresses IL-21 production from follicular Th cells and subsequent humoral immune responses.
    Authors: Kashiwakuma D, Suto A, Hiramatsu Y
    J. Immunol., 2010-07-26;185(5):2730-6.
    Species: Mouse
    Sample Types: Whole Cells
    Applications: Bioassay
  30. VEGFR2 is selectively expressed by FOXP3high CD4+ Treg.
    Authors: Suzuki H, Onishi H, Wada J, Yamasaki A, Tanaka H, Nakano K, Morisaki T, Katano M
    Eur. J. Immunol., 2010-01-01;40(1):197-203.
    Species: Human
    Sample Types: Whole Cells
    Applications: Bioassay
  31. Gram-positive bacteria enhance HIV-1 susceptibility in Langerhans cells, but not in dendritic cells, via Toll-like receptor activation.
    Authors: Ogawa Y, Kawamura T, Kimura T, Ito M, Blauvelt A, Shimada S
    Blood, 2009-03-11;113(21):5157-66.
    Species: Human
    Sample Types: Whole Cells
    Applications: Bioassay
  32. Pax3 activation promotes the differentiation of mesenchymal stem cells toward the myogenic lineage.
    Authors: Gang EJ, Bosnakovski D, Simsek T, To K, Perlingeiro RC
    Exp. Cell Res., 2008-03-05;314(8):1721-33.
    Species: Mouse
    Sample Types: Whole Cells
    Applications: Bioassay
  33. Activin A is an anticatabolic autocrine cytokine in articular cartilage whose production is controlled by fibroblast growth factor 2 and NF-kappaB.
    Authors: Alexander S, Watt F, Sawaji Y, Hermansson M, Saklatvala J
    Arthritis Rheum., 2007-11-01;56(11):3715-25.
    Species: Human, Porcine
    Sample Types: Whole Cells
    Applications: Bioassay
  34. Characterization of human lung tumor-associated fibroblasts and their ability to modulate the activation of tumor-associated T cells.
    Authors: Nazareth MR, Broderick L, Simpson-Abelson MR, Kelleher RJ, Yokota SJ, Bankert RB
    J. Immunol., 2007-05-01;178(9):5552-62.
    Species: Human
    Sample Types:
    Applications: Bioassay
  35. Increase in transforming growth factor-beta in the brain during infection is related to fever, not depression of spontaneous motor activity.
    Authors: Matsumura S, Shibakusa T, Fujikawa T, Yamada H, Inoue K, Fushiki T
    Neuroscience, 2006-12-06;144(3):1133-40.
    Species: Rat
    Sample Types: In Vivo, Serum
    Applications: Bioassay, In Vivo
  36. Identification of BMP9 and BMP10 as functional activators of the orphan activin receptor-like kinase 1 (ALK1) in endothelial cells.
    Authors: David L, Mallet C, Mazerbourg S, Feige JJ, Bailly S
    Blood, 2006-10-26;109(5):1953-61.
    Species: Human
    Sample Types: Whole Cells
    Applications: Bioassay
  37. Canonical Wnt signaling is required for development of embryonic stem cell-derived mesoderm.
    Authors: Lindsley RC, Gill JG, Kyba M, Murphy TL, Murphy KM
    Development, 2006-08-30;133(19):3787-96.
    Species: Mouse
    Sample Types: Whole Cells
    Applications: Bioassay
  38. trans fatty acids and systemic inflammation in heart failure.
    Authors: Mozaffarian D, Rimm EB, King IB, Lawler RL, McDonald GB, Levy WC
    Am. J. Clin. Nutr., 2004-12-01;80(6):1521-5.
    Applications: ELISA (Standard)
  39. Interferon-gamma inhibits transforming growth factor-beta production in human airway epithelial cells by targeting Smads.
    Authors: Wen FQ, Liu X, Kobayashi T, Abe S, Fang Q, Kohyama T, Ertl R, Terasaki Y, Manouilova L, Rennard SI
    Am. J. Respir. Cell Mol. Biol., 2004-01-12;30(6):816-22.
    Species: Human
    Sample Types: Whole Cells
    Applications: Bioassay
  40. Dual regulation of proliferation and growth arrest in prostatic stromal cells by transforming growth factor-beta1.
    Authors: Zhou W, Park I, Pins M, Kozlowski JM, Jovanovic B, Zhang J, Lee C, Ilio K
    Endocrinology, 2003-07-24;144(10):4280-4.
    Species: Human
    Sample Types: Whole Cells
    Applications: Bioassay
  41. Transforming growth factor-beta -Smad signaling pathway cooperates with NF-kappa B to mediate nontypeable Haemophilus influenzae-induced MUC2 mucin transcription.
    Authors: Jono H, Shuto T, Xu H, Kai H, Lim DJ, Gum JR, Kim YS, Yamaoka S, Feng XH, Li JD
    J. Biol. Chem., 2002-09-16;277(47):45547-57.
    Species: Human
    Sample Types: Whole Cells
    Applications: Bioassay
  42. Transforming growth factor beta(1) selectively inhibits the cyclic AMP-dependent proliferation of primary thyroid epithelial cells by preventing the association of cyclin D3-cdk4 with nuclear p27(kip1).
    Authors: Depoortere F, Pirson I, Bartek J, Dumont JE, Roger PP
    Mol. Biol. Cell, 2000-03-01;11(3):1061-76.
    Species: Canine
    Sample Types: Whole Cells
    Applications: Bioassay
  43. Macrophages that have ingested apoptotic cells in vitro inhibit proinflammatory cytokine production through autocrine/paracrine mechanisms involving TGF-beta, PGE2, and PAF.
    Authors: Fadok, V A, Bratton, D L, Konowal, A, Freed, P W, Westcott, J Y, Henson, P M
    J Clin Invest, 1998-02-15;101(4):890-8.
    Species: Human
    Sample Types: Whole Cells
    Applications: Bioassay

FAQs

No product specific FAQs exist for this product, however you may

View all Proteins and Enzyme FAQs

Reviews for Human TGF-beta 1 Protein

Average Rating: 5 (Based on 4 Reviews)

5 Star
100%
4 Star
0%
3 Star
0%
2 Star
0%
1 Star
0%

Have you used Human TGF-beta 1 Protein?

Submit a review and receive an Amazon gift card.

$25/€18/£15/$25CAN/¥75 Yuan/¥2500 Yen for a review with an image

$10/€7/£6/$10 CAD/¥70 Yuan/¥1110 Yen for a review without an image

Submit a Review

Filter by:


Human TGF-beta 1 Protein
By Anonymous on 08/17/2020
Application: Evaluation of fibrosis induction after TGFb treatment.
Other Human TGF-beta 1 Protein 100-B
Human TGF-beta 1 Protein
By Leo Zhelnin on 11/03/2017
Application: In vitro bioactivity in cell culture
Reason for Rating: Excellent response in cell tissue studies at the NM level concentration
Human TGF-beta 1 Protein
By Anonymous on 07/31/2017
Application: Immunoassay Standard
Human TGF-beta 1 Protein
By Anonymous on 07/21/2017
Application: In vitro bioactivity in cell culture